Article Figures & Data
Figures
- Figure 1
Effect of measles vaccine on incidence of measles in the United States.
From the US Centers for Disease Control and Prevention.
- Figure 2
Koplik spots arise during the viral prodrome and are critical for the clinical diagnosis of measles before the onset of rash.
From the US Centers for Disease Control and Prevention.
- Figure 3
Morbilliform rash of measles.
From the US Centers for Disease Control and Prevention.
Tables
Vitamin A once daily for 2 days, at the following doses: Children 12 months of age or older: 200,000 IU Infants 6–11 months of age: 100,000 IU Infants < 6 months: 50,000 IU Another dose is recommended 4–6 weeks after the onset of the acute infection if vitamin A deficiency is likely to be present. Information from reference 5.
Patient category Recommendations Routine vaccination Patient with no evidence of immunity to measles, mumps, or rubella (see Table 3) Give 1 dose of measles, mumps, and rubella (MMR) vaccine Special situations Pregnancy with no evidence of immunity to rubella MMR is contraindicated during pregnancy After pregnancy (before discharge from healthcare facility), give 1 dose of MMR Nonpregnant women of childbearing age with no evidence of immunity to rubella Give 1 dose of MMR Human immunodeficiency virus (HIV) infection with CD4 count ≥ 200 cells/μL for at least 6 months and no evidence of immunity to measles, mumps, or rubella Give 2-dose series of MMR at least 4 weeks apart MMR is contraindicated in HIV infection with CD4 count < 200 cells/μL Severe immunocompromising conditions MMR is contraindicated Students in postsecondary educational institutions, international travelers, and household or close personal contacts of immunocompromised persons with no evidence of immunity to measles, mumps, or rubella 1 dose MMR if previously received 1 dose MMR, or 2-dose series MMR at least 4 weeks apart if previously did not receive any MMR Healthcare personnel born in 1957 or later with no evidence of immunity to measles, mumps, or rubella 2-dose series MMR at least 4 weeks apart for measles or mumps, or at least 1 dose MMR for rubella; if born before 1957, consider 2-dose series MMR at least 4 weeks apart for measles or mumps, or 1 dose MMR for rubella From the US Centers for Disease Control and Prevention.
- TABLE 3
US Centers for Disease Control and Prevention criteria for evidence of immunity to measles
At least one of the following: Written documentation of adequate vaccinations including 1 or more doses of measles vaccine given after 12 months of age (preschool-age children) and adults “not at high risk” Written documentation of 2 doses of vaccine for school-age children and adults at high risk: college students, healthcare personnel, and international travelers Laboratory evidence of immunity Laboratory confirmation of measles Birth before 1957 Information from reference 4.
